Role of three-body recombination for charge reduction in MALDI process

Analyst. 2013 May 21;138(10):2964-9. doi: 10.1039/c3an36749e.

Abstract

Ions in Matrix-Assisted Laser Desorption/Ionization (MALDI) are predominantly singly charged for small analyte molecules. With the estimated high number density and low temperature of electrons, the three-body recombination mechanism is attractive and should be considered as an important cause for the charge reduction in the plume. Theoretical calculations indicate that the rate coefficient of the three-body recombination is about 50 times higher than that of the two-body recombination if the analyte molecule has insufficient degrees of freedom. Experimental results show that, for small analyte molecules, the ratio of AH2(2+)/AH(+) is close to the theoretical 5% value from the three-body recombination modeling and this ratio declines with the increasing electron and matrix molecule number density caused by greater laser irradiance. The ratio of [A + 2](+)/[A + 1](+) is higher than the theoretical isotopic value, and the excess [A + 2](+) could exclusively result from the three-body recombination collisions. Further evidence demonstrates that [A + 2](+)/[A + 1](+) increases with electron number density, which is in correspondence with the model. All of these theoretical and experimental results indicate that three-body recombination is an essential charge reduction mechanism for small molecules in the MALDI plume.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacitracin / analysis*
  • Coumaric Acids / chemistry*
  • Gentisates / chemistry*
  • Lasers
  • Muramidase / analysis*
  • Muramidase / metabolism
  • Oncogene Protein pp60(v-src) / analysis*
  • Oxidation-Reduction
  • Peptide Fragments / analysis*
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Substances

  • Coumaric Acids
  • Gentisates
  • Peptide Fragments
  • peptide A
  • Bacitracin
  • alpha-cyano-4-hydroxycinnamate
  • bacitracin A
  • Oncogene Protein pp60(v-src)
  • Muramidase
  • 2,5-dihydroxybenzoic acid